Diagnósticos da América : Strong Q1 growth in revenue, EBITDA, and cash flow, with premium and B2B segments leading

About this update from Diagnosticos Da America S.a.

Q1 2026 saw strong revenue and EBITDA growth, margin expansion, and improved cash flow, driven by diagnostics, premium, and home care segments. Leverage and CapEx were reduced, with investments focused on technology and efficiency. Premium and B2B channels remain key growth drivers.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Diagnosticos Da America S.a.